Skip to main content

Table 2 Mean UAS throughout treatment

From: Omalizumab for chronic urticaria in Latin America

Time (months) No. of patients Mean UAS (SD)
Baseline 26 5.6 (0.6)
1 26 3.4 (1.3)
2 13 2.7 (1.5)
3 9 2.3 (1.7)
4 6 1.3 (0.8)
5 4 2.0 (2.0)
  1. UAS urticaria activity score